Evidence map›Paper›PMID 42764840›Full record

ArticleCrohn's & colitis 3602026

Attentional variability as a cognitive marker of clinical activity in Crohn's disease.

Andreza Maia, Juliana Janeiro Schmidt, Carlos Eduardo Brandão Mello, Guilherme Janeiro Schmidt, Yolanda Faia Manhães Tolentino, Márcia Maria Amendola Pires, Ana Caroliny da Silva, Julia Dias Guimarães Silva, Marcia Lyrio Sindorf, Sergio Luis Schmidt

Abstract read
In one paragraph

Article in Crohn's & colitis 360, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Andreza MaiaPos Graduate Program in Neurology (PPGNEURO), Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.ORCID https://orcid.org/0009-0006-2817-7045
Juliana Janeiro SchmidtPos Graduate Program in Neurology (PPGNEURO), Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.ORCID https://orcid.org/0000-0002-3949-2984
Carlos Eduardo Brandão MelloPos Graduate Program in Neurology (PPGNEURO), Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.ORCID https://orcid.org/0000-0001-8965-6556
Guilherme Janeiro SchmidtPos Graduate Program in Neurology (PPGNEURO), Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.
Yolanda Faia Manhães TolentinoDepartment of Gastroenterology, Gaffrée and Guinle University Hospital (HUGG), Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.
Márcia Maria Amendola PiresDepartment of Gastroenterology, Gaffrée and Guinle University Hospital (HUGG), Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.
Ana Caroliny da SilvaUndergraduate Research Program, Gaffrée and Guinle University Hospital (HUGG), Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.
Julia Dias Guimarães SilvaUndergraduate Research Program, Gaffrée and Guinle University Hospital (HUGG), Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.
Marcia Lyrio SindorfDepartment of Gastroenterology, Gaffrée and Guinle University Hospital (HUGG), Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.
Sergio Luis SchmidtPos Graduate Program in Neurology (PPGNEURO), Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Brazil.ORCID https://orcid.org/0000-0001-7654-5507

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Behavioral and cognitive manifestations have been increasingly recognized in Crohn disease (CD), yet the specific behavioral domains associated with clinical activity remain incompletely characterized. Although reduced response speed has been proposed as a key feature, moment-to-moment fluctuations in performance may better capture behavioral instability related to systemic inflammation. We examined behavioral variability and attentional performance in CD and their relationship with clinical activity. Methods: In this case-control study, patients with CD of at least 1 year's duration ( Results: Fifty percent of patients with CD were in clinical remission. Compared with controls, patients with CD demonstrated significantly greater attentional variability and higher omission error rates, whereas mean response speed did not differ significantly. Within the CD cohort, sustained attention was significantly associated with disease activity and was the only subdomain predicting HBI scores. Patients in clinical remission continued to show impairments in sustained and focused attention compared with controls, whereas response speed was unaffected. Conclusion: CD is associated with selective alterations in attentional stability rather than generalized slowing. Attentional variability tracks clinical activity and remains detectable during remission, suggesting that sustained attention may represent a sensitive cognitive marker of ongoing disease impact.

Indexed as

cognitive impairmentCrohn’s diseaseextra-intestinal manifestations of inflammatory bowel diseasesneuropsychological assessmentsustained attention

Identifiers

PMID42764840
PMCPMC13589784

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.